SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Clinical trials for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 explained in plain language.
Never miss a new study
Get alerted when new SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 trials appear
Sign up with your email to follow new studies for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COVID-19 vaccine trial aims to protect kids from latest variants
⭐️ VACCINE ⭐️ OngoingThis large study is testing updated mRNA vaccines designed to protect against newer Omicron variants of COVID-19 in healthy children aged 6 months to 12 years. Over 4,000 participants will receive one or more doses depending on their age and vaccination history. Researchers are m…
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:06 UTC
-
COVID lung damage: who gets scarred?
Knowledge-focused OngoingThis study follows 200 ICU patients with severe COVID-19 to see how often they develop lung scarring (pulmonary fibrosis). Researchers will use blood tests and CT scans to find early signs of scarring and identify risk factors. The goal is to understand how scarring affects recov…
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC